Veracyte, Inc. (VCYT) stock
VCYTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3034% below fair value
$24.23+0.22 (+0.92%)
Close on Nov 17, 2026Market cap $1.95BP/E 17.3Yield –
Veracyte operating margin
Operating margin is operating income as a percentage of revenue.
Veracyte's operating margin for the twelve months ending Jun 30, 2026 was 18.8%. For fiscal 2025 it was 11.2%, against 3.6% the year before. The highest annual figure on record is 11.2% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 11.2% | +7.6 |
| FY2024 | Dec 31, 2024 | 3.6% | +27.4 |
| FY2023 | Dec 31, 2023 | -23.8% | −9.9 |
| FY2022 | Dec 31, 2022 | -13.9% | +23.5 |
| FY2021 | Dec 31, 2021 | -37.3% | −7.2 |
| FY2020 | Dec 31, 2020 | -30.1% | −17.6 |
| FY2019 | Dec 31, 2019 | -12.6% | +11.6 |
| FY2018 | Dec 31, 2018 | -24.2% | +12.7 |
| FY2017 | Dec 31, 2017 | -36.9% | +7.4 |
| FY2016 | Dec 31, 2016 | -44.3% | +23.3 |
| FY2015 | Dec 31, 2015 | -67.6% | +8.3 |
| FY2014 | Dec 31, 2014 | -76.0% | +29.9 |
| FY2013 | Dec 31, 2013 | -105.9% | +56.9 |
| FY2012 | Dec 31, 2012 | -162.8% | +414.4 |
| FY2011 | Dec 31, 2011 | -577.2% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 15.3% | +19.3 |
| Q1 FY2026 | Mar 31, 2026 | 16.3% | +13.7 |
| Q4 FY2025 | Dec 31, 2025 | 26.4% | +22.9 |
| Q3 FY2025 | Sep 30, 2025 | 17.4% | +7.0 |
| Q2 FY2025 | Jun 30, 2025 | -4.0% | −8.1 |
| Q1 FY2025 | Mar 31, 2025 | 2.5% | +7.3 |
| Q4 FY2024 | Dec 31, 2024 | 3.5% | +39.7 |
| Q3 FY2024 | Sep 30, 2024 | 10.4% | +45.6 |
| Q2 FY2024 | Jun 30, 2024 | 4.0% | +12.9 |
| Q1 FY2024 | Mar 31, 2024 | -4.8% | +7.9 |
| Q4 FY2023 | Dec 31, 2023 | -36.2% | −29.4 |
| Q3 FY2023 | Sep 30, 2023 | -35.2% | −22.4 |
| Q2 FY2023 | Jun 30, 2023 | -8.9% | +5.8 |
| Q1 FY2023 | Mar 31, 2023 | -12.7% | +9.8 |
| Q4 FY2022 | Dec 31, 2022 | -6.7% | +11.6 |
| Q3 FY2022 | Sep 30, 2022 | -12.8% | +14.8 |
| Q2 FY2022 | Jun 30, 2022 | -14.7% | −1.2 |
| Q1 FY2022 | Mar 31, 2022 | -22.5% | +101.2 |
| Q4 FY2021 | Dec 31, 2021 | -18.3% | +5.1 |
| Q3 FY2021 | Sep 30, 2021 | -27.6% | −14.6 |
| Q2 FY2021 | Jun 30, 2021 | -13.6% | +39.8 |
| Q1 FY2021 | Mar 31, 2021 | -123.7% | −84.5 |
| Q4 FY2020 | Dec 31, 2020 | -23.4% | +4.2 |
| Q3 FY2020 | Sep 30, 2020 | -13.1% | −7.4 |
| Q2 FY2020 | Jun 30, 2020 | -53.4% | −43.1 |
| Q1 FY2020 | Mar 31, 2020 | -39.2% | −32.2 |
| Q4 FY2019 | Dec 31, 2019 | -27.6% | −15.7 |
| Q3 FY2019 | Sep 30, 2019 | -5.7% | +12.6 |
| Q2 FY2019 | Jun 30, 2019 | -10.3% | +15.7 |
| Q1 FY2019 | Mar 31, 2019 | -7.0% | +37.7 |
| Q4 FY2018 | Dec 31, 2018 | -11.9% | +19.0 |
| Q3 FY2018 | Sep 30, 2018 | -18.3% | +18.0 |
| Q2 FY2018 | Jun 30, 2018 | -26.0% | +9.9 |
| Q1 FY2018 | Mar 31, 2018 | -44.7% | +1.1 |
| Q4 FY2017 | Dec 31, 2017 | -30.8% | −10.7 |
| Q3 FY2017 | Sep 30, 2017 | -36.3% | −10.1 |
| Q2 FY2017 | Jun 30, 2017 | -35.9% | – |
| Q1 FY2017 | Mar 31, 2017 | -45.7% | – |
| Q4 FY2016 | Dec 31, 2016 | -20.1% | – |
| Q3 FY2016 | Sep 30, 2016 | -26.3% | – |
See a number that looks wrong?